Clinical Trials
87
Trial Phases
5 Phases
Drug Approvals
4
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (77 trials with phase data)• Click on a phase to view related trials
FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis
- Conditions
- Congenital AfibrinogenemiaHypofibrinogenemia
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Instituto Grifols, S.A.
- Registration Number
- NCT04636268
A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
- Conditions
- COVID-19
- Interventions
- Biological: Convalescent anti-SARS-CoV-2 MBT PlasmaDrug: Standard Medical Treatment
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 200
- Registration Number
- NCT04547127
- Locations
- 🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain
Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19
- Conditions
- COVID-19
- Interventions
- Biological: ProlastinDrug: Standard Medical Treatment
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 100
- Registration Number
- NCT04495101
- Locations
- 🇪🇸
Hospital Universitario de Burgos, Burgos, Castilla León, Spain
🇪🇸Hospital Universitari Germans Trias i Pujol, Badalona, Spain
🇪🇸Hospital Clínic de Barcelona, Barcelona, Spain
Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
- Conditions
- COVID-19
- Interventions
- Biological: Intravenous Immune GlobulinDrug: Standard Medical Treatment
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 100
- Registration Number
- NCT04432324
- Locations
- 🇪🇸
Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain
🇪🇸Hospital Germans Trias i Pujol, Badalona, Spain
🇪🇸Hospital Del Mar, Barcelona, Spain
A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants
- Conditions
- Excessive Bleeding During Surgery
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 186
- Registration Number
- NCT03461406
- Locations
- 🇺🇸
Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
🇺🇸University of Michigan, Michigan Center, Michigan, United States
🇺🇸The Urological Institute of Northeastern New York, Albany, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next